August 24–28, 2020
Boston, MA, USA
Don't miss the opportunity to see how Genedata solutions efficiently support the whole biopharmaceutical R&D workflow, including screening and protein engineering, expression and purification, characterization and analysis of protein therapeutics, cell line design and development, bioprocess optimization, and quality control of biologicals.
To schedule a meeting in advance or to get more information about Genedata solutions, please contact firstname.lastname@example.org.
Efficiency Gains by Integrating Automated and Manual Cell Line Development Workflows in One End-to-End Platform
Andrew Lynch, Ph.D., Scientific Consultant, Genedata Inc.
We have developed an E2E platform that supports the entire bioprocess development workflow by automating cell line development and managing upstream process, downstream process, analytical and formulation development. The system directly integrates with instruments and enables informed decision-making via its query and reporting infrastructure. We present efficiency and quality gains in cell line and upstream process development as well as viral vector production.